ITRM Live signals | Maximize Profits with Getagraph.com

BUY 123593 min ago

@ $1.650

Issued: 7 Feb 2024 @ 16:00

Return: -5.45%

Previous signal: Feb 7 - 13:28

Previous signal: Sell

Return: -3.79 %

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 12:35):

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States...

Stats
Today's Volume	25 828.00
Average Volume	203 875
Market Cap	25.83M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.570 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.530
ATR14	$0.0150 (0.96%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-22	Dunne Michael W.	Buy	25 000	Ordinary Shares
2023-12-18	Dunne Michael W.	Buy	10 000	Ordinary Shares
2023-12-01	Puttagunta Sailaja	Sell	8 333	Restricted Share Units
2023-12-01	Puttagunta Sailaja	Buy	8 333	Ordinary Shares
2023-12-01	Puttagunta Sailaja	Sell	2 933	Ordinary Shares

INSIDER POWER
76.06
Last 98 transactions
Buy: 8 259 885 \| Sell: 825 272

Volume Correlation

Long: 0.13 (neutral)

Short: 0.85 (strong)

Signal:(46.197) Same movement expected

Iterum Therapeutics PLC Correlation

10 Most Positive Correlations
RMRM	0.924
TLGT	0.921
NEPT	0.915
SVAC	0.906
PAIC	0.9
WTER	0.9
LPTX	0.885
NXTC	0.866
PSTV	0.866
INVE	0.863

10 Most Negative Correlations
AMRB	-0.953
MMAC	-0.928
NETE	-0.918
BILI	-0.869
BSMS	-0.867
BOCH	-0.864
BSMR	-0.862
BSMT	-0.858
BNIXU	-0.858
BSMU	-0.854

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Iterum Therapeutics PLC Correlation - Currency/Commodity

-0.32
( neutral )

-0.23
( neutral )

0.00
( neutral )

-0.30
( neutral )

0.07
( neutral )

-0.14
( neutral )

Iterum Therapeutics PLC Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.75M (0.00 %)
EPS:	$-2.96

FY	2023
Revenue:	$0
Gross Profit:	$-1.75M (0.00 %)
EPS:	$-2.96

FY	2022
Revenue:	$0
Gross Profit:	$-1.80M (0.00 %)
EPS:	$-3.63

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-57.20

Financial Reports:

No articles found.

Iterum Therapeutics PLC

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.